CLINICAL_TRIALS
trial_result
· 2019-05-31
Clinical Trial Update: Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients [Phase 4]
Summary
Phase 4 randomized trial evaluating conversion strategies for calcineurin inhibitors in renal transplant recipients; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Northwestern University | Conditions: Renal Transplant Rejection | Phase 4 | Status: COMPLETED | Results posted: 2019-05-31